Also, Ryan et al. showed that only a minority of T1D patients (approximately 10%) who underwent islet transplantation were able to maintain insulin independence over a 5-year follow-up period, despite ongoing evidence of persistent graft function, as indicated by restored C-peptide secretion [8]. The gene discussed is INS; the disease is type 1 diabetes mellitus.